Aniruddha JainThemis Medicare Limited (“TML” or “Transferee Company”) is engaged in the business of manufacturing of finished formulations and synthetic Active Pharmaceutical Ingredients (“APIs”). The equity shares of TML are listed on the Stock Exchanges.
In 2022, TML decided to transfer its entire API business to its wholly owned subsidiary through slump sale which was pending ...
Already a user? Sign in
